Old Web
English
Sign In
Acemap
>
authorDetail
>
Bryan D. Lemon
Bryan D. Lemon
T cell
Medicine
Cancer research
Biology
CD3
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients with metastatic castration-resistant prostate cancer (mCRPC).
2020
Journal of Clinical Oncology
Johanna C. Bendell
Lawrence Fong
Mark N. Stein
Tomasz M. Beer
Ashley E. Ross
Xin Gao
Aaron Weitzman
Richard C. Austin
Vaishnavi Ganti
Che Leung Law
Bryan D. Lemon
Holger Wesche
Johann S. de Bono
Show All
Source
Cite
Save
Citations (9)
Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer
2019
Molecular Cancer Therapeutics
Wade Aaron
Richard J. Austin
Manasi Barath
Evan Callihan
Michael Cremin
Thomas J. Evans
María Gámez
Vaishnavi Ganti
Golzar Hemmati
Kathryn Kwant
Che Leung Law
Bryan D. Lemon
Llewelyn Lao
Mary Ellen Molloy
Jessica O'rear
Laura Sun
Holger Wesche
Stephen Yu
Timothy. Yu
Show All
Source
Cite
Save
Citations (0)
Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma
2018
Blood
Che-leung. Law
Wade Aaron
Rick Austin
Manasi Barath
Evan Callihan
Thomas J. Evans
María Gámez Guerrero
Golzar Hemmati
A Jones
Kathryn Kwant
Llewelyn Lao
Bryan D. Lemon
Katrine Moldt
Purbasa Patnaik
Kenneth Sexton
Holger Wesche
Yinghua Xiao
Stephen Yu
Timothy. Yu
Show All
Source
Cite
Save
Citations (12)
Trispecific proteins and methods of use
2018
Holger Wesche
Bryan D. Lemon
Richard J. Austin
Show All
Source
Cite
Save
Citations (0)
1